The International Lyme and Associated Diseases Society. Evidence-based guidelines of the management of Lyme disease

Expert Review of Anti-Infective Therapy

Volumn 2, Issue 1 SUPPL., 2004, Pages

  Cameron, Daniel ^a,b   Gaito, Andrea ^a,b   Harris, Nick ^a,b   Bach, Gregory ^a,b   Bellovin, Sabra ^a,b   Bock, Kenneth ^a,b   Bock, Steven ^a,b   Burrascano, Joseph ^a,b   Dickey, Constance ^a,b   Horowitz, Richard ^a,b   Phillips, Steven ^a,b   Meer Scherrer, Laurence ^a,b   Raxlen, Bernard ^a,b   Sherr, Virginia ^a,b   Smith, Harold ^a,c   Smith, Pat ^a,b   Stricker, Raphael ^a  

^a ILADS   (United States)

^b Dept of Internal Med/Epidemiology ^*  (United States)

^c Lyme Disease Association Inc   (United States)

Author keywords

Antibiotics; Babesia; Bartonella; Borrelia burgdorferi; Ehrlichia; Guidelines; Lyme disease; Tickborne diseases

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; ATOVAQUONE; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFDINIR; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; COLESTYRAMINE; CORTICOSTEROID; DOXYCYCLINE; HYDROXYCHLOROQUINE; IMIPENEM; METRONIDAZOLE; PENICILLIN G; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SEROTONIN UPTAKE INHIBITOR; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BABESIA MICROTI; BACTERIAL SUPERINFECTION; BARTONELLA; BORRELIA BURGDORFERI; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COLITIS; COMPETENCE; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFICACY; EHRLICHIA; EPIDEMIC; EVIDENCE BASED MEDICINE; FIBROMYALGIA; GASTROINTESTINAL DISEASE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HOMEOPATHY; HUMAN; LYME DISEASE; MEDICAL EDUCATION; MEDICAL SOCIETY; NEUROPATHY; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SYNOVECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 2942529193     PISSN: 14787210     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Goldoft MJ, Schulze TL, Parkin WE, Gunn RA. Lyme disease in New Jersey. NJ Med. 87, 579-584 (1990).
2. CDC. Lyme disease-United States, 2000. MMWR 51, 29-31 (2002).
3. Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann. Intern. Med. 121, 560-567 (1994).
4. Asch ES, Bujak DI, Weiss M, Peterson MGE, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J. Rheumatol. 21, 454-456 (1994).
5. Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin. Infect. Dis. 32, 897-928 (2001).
6. Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin. Infect. Dis. 31(Suppl. 1), 1-14 (2000).
7. Rahn DW, Malawista SE. Lyme disease: recommendations for diagnosis and treatment. Ann. Intern. Med. 114, 472-481 (1991).
8. Feder HM Jr. Differences are voiced by two Lyme camps at a Connecticut public hearing on insurance coverage of Lyme disease. Pediatrics 105(4 Pt 1), 855-857 (2000).
9. Burrascano JJ. Lyme disease. In: Conn's Current Therapy. WB Saunders Company, PA, USA 140-143 (1997).
10. Kish MA. Guide to development of practice guidelines. Clin. Infect. Dis. 32, 851-854 (2001).
11. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, Steele FM. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20, 7-17 (1977).
12. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 323, 1438-1444 (1990).
13. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am. J. Psychiatry 151, 1571-1583 (1994).
14. Tylewska-Wierzbanowska S, Chmielewski T. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods. Wien Klin Wochenschr. 114, 601-605 (2002).
15. Halperin JJ. Neuroborreliosis. Am. J. Med. 98(4A), 52S-59S (1995).
16. Battaglia HR, Alvarez G, Mercau A, Fay M, Campodónico M. Psychiatric symptomatology associated with presumptive Lyme disease: Clinical evidence. J. Spiro Tick Dis. 7, 22-25 (2000).
17. Corsaro L Intramuscular Bicillin for persistent pediatric Lyme disease. Proceedings of the 9th International Conference on Lyme Borreliosis & Other Tick-borne Disorders (1999).
18. Cimmino MA, Accardo S. Long-term treatment of chronic Lyme arthritis with benzathine penicillin. Ann. Rheum. Dis. 51, 1007-1008 (1992).
19. Fallon BA, Tager F, Keilp J, Weiss N, Liebowitz MR, Fein L, Liegner K. Repeated antibiotic treatment in chronic Lyme disease. J. Spiro Tick Dis. 6, 94-102 (1999).
20. Lawrence C, Lipton RB, Lowy FD, Coyle PK. Seronegative chronic relapsing neuroborreliosis. Eur. Neurol. 35, 113-117 (1995).
21. Cameron DJ. Monitoring Lyme disease in the community - First surveillance database sentinel health site. Proceedings of the 12th Annual International Scientific Conference on Lyme Disease and Other Spirochetal and Tick-Borne Disorders (1999).
22. Fallon BA, Kochevar JM, Gaito A, Nields JA. The underdiagnosis of neuropsychiatric Lyme disease in children and adults. Psychiatr. Clin. North Am. 21, 693-703 (1998).
23. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345, 85-92 (2001).
24. Dinerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann. Intern. Med. 117, 281-285 (1992).
25. Stricker RB, Lautin A. The Lyme wars: time to listen. Expert Opin. Investig. Drugs 12, 1609-1614 (2003).
26. Nadelman RB, Wormser GP. Erythema migrans and early Lyme disease. Am. J. Med. 98(4A), S15-S24 (1995).
27. Nowakowski J, McKenna D, Nadelman RB et al. Failure of treatment with cephalexin for Lyme disease. Arch. Fam. Med. 9, 563-567 (2000).
28. Steere AC, Broderick TF, Malawista SE. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidence for a tick vector. Am. J. Epidemiol. 108, 312-321 (1978).
29. Petrovic M, Vogelaers D, Van Renterghem L, Carton D, De Reuck J, Afschrift M. Lyme borreliosis - a review of the late stages and treatment of four cases. Acta Clin. Belg. 53, 178-183 (1998).
30. Tilton RC, Sand MN, Manak M. The Western immunoblot for Lyme disease: determination of sensitivity, specificity and interpretive criteria with use of commercially available performance panels. Clin. Infect. Dis. 25 (Suppl. 1), S31-S34 (1997).
31. CDC. Recommendations for test performance and interpretation from the second national conference on serologic diagnosis of Lyme disease. MMWR 44, 590-591 (1995).
32. Trevejo RT, Krause PJ, Sikand VK, Schriefer ME, Ryan R, Lepore T, Porter W, Dennis DT. Evaluation of two-test serodiagnostic method for early Lyme disease in clinical practice. J. Infect. Dis. 179, 931-938 (1999).
33. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, Wormser GP. Serodiagnosis in early Lyme disease. J. Clin. Microbiol. 31, 3090-3095 (1993).
34. Harris N. An understanding of laboratory testing for Lyme disease. J. Spiro Tick Dis. 5, 16-26 (1998).
35. Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 30, 370-376 (1992).
36. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 33, 419-427 (1995).
37. Magnarelli LA. Laboratory analyses for Lyme disease. Conn. Med. 53, 331-334 (1989).
38. Krause PJ, Telford S, Spielman A, Sikand VJ, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing DH. Concurrent Lyme disease and Babesiosis: Evidence for increased severity and duration of illness. JAMA 275, 1657-1660 (1996).
39. Luft BJ, Dattwyler RJ, Johnson RC et al. Azithromycin compared with amoxicillin in the treatment of erythema migrans: a double-blind, randomized, controlled trial. Ann. Intern. Med. 124, 785-791 (1996).
40. Dattwyler RJ, Luft BJ, Kunkel M et al. Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N. Engl. J. Med. 337, 289-294 (1997).
41. Barsic B, Maretic T, Majerus L, Strugar J. Comparison of azithromycin and doxycycline in the treatment of erythema migrans. Infection 28, 153-156 (2000).
42. Scott LJ, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs 61, 1455-1500 (2001).
43. Dattwyler RJ, Grunwaldt E, Luft BJ. Clarithromycin in treatment of early Lyme disease: a pilot study. Antimicrob. Agents Chemother. 40, 468-469 (1996).
44. Karlsson M, Hammers-Berggren S, Lindquist L et al. Comparison of iv. penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44, 1203-1207 (1994).
45. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin. Infect. Dis. 28, 569-574 (1999).
46. Luft BJ, Volkman DJ, Halperin JJ, Dattwyler RJ. New chemotherapeutic approaches in the treatment of Lyme borreliosis. Ann. NY Acad. Sci. 539, 352-361 (1988).
47. Battaglia HR, Alvarez G, Mercau A, Fay M, Campodónico M. Psychiatric symptomatology associated with presumptive Lyme disease: clinical evidence. J. Spirol. Tick Dis. 7, 22-25 (2000).
48. Ziska MH, Donta ST, Demarest FC. Physician preferences in the diagnosis and treatment of Lyme disease in the United States. Infection 24, 182-186 (1996).
49. Culp RW, Eichenfield AH, Davidson RS, Drummond DS, Christofersen MR, Goldsmith DP. Lyme arthritis in children. An orthopedic perspective. J. Bone Joint Surg. Am. 69, 96-99 (1987).
50. Weiss LM. Babesiosis in humans: a treatment review. Expert Opin. Pharmacother. 3, 1109-1115 (2002).
51. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with iv. ceftriaxone. J. Infect. Dis. 180, 377-383 (1999).
52. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet 1191-1194 (1988).
53. Schoen RT, Aversa JM, Rahn DW, Steere AC. Treatment of refractory chronic Lyme arthritis with arthroscopic synovectomy. Arthritis Rheum. 34, 1056-1060 (1991).
54. Pavia CS. Current and novel therapies for Lyme disease. Expert Opin. Investig. Drugs 12, 1003-1016 (2003).
55. Krause PJ, Lepore T, Sikand VK et al. Atovaquone and azithromycin for the treatment of babesiosis. N. Engl. J. Med. 343, 1454-1458 (2000).
56. Steere AC, Green J, Schoen RT et al. Successful parenteral penicillin therapy of established Lyme arthritis. N. Engl. J. Med. 312, 869-874 (1985).
57. Fallon BA. Chronic Lyme Disease Research Study. A double-blind placebo-controlled randomized clinical trial evaluating the efficacy of ten weeks of iv. ceftriaxone and effects on brain imaging. Enrollment since 2000.
58. Cameron DJ. Lyme Disease Retreatment Study. A double-blind placebo-controlled randomized clinical trial evaluating the efficacy of oral amoxicillin for seropositive and seronegative Lyme disease. Enrollment since 2001.
59. Eppes SC, Klein JD, Caputo G, Rose CD. Physician beliefs, attitudes and approaches toward Lyme disease in an endemic area. Clin. Pediatr. 33, 130-134 (1994).
60. Peña CA, Mathews AA, Siddiqi NH, Strickland GT. Antibiotic therapy for Lyme disease in a population-based cohort. Clin. Infect. Dis. 29, 694-695 (1999).
61. Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I. Treatment of late Lyme borreliosis. J. Infect. 29, 255-261 (1994).
62. Donta ST. Tetracycline therapy for chronic Lyme disease. Clin. Infect Dis. 25 (Suppl. 1), S52-S56 (1997).
63. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann. Intern. Med. 128, 354-362 (1998).
64. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 269, 1812-1816 (1993).
65. Sigal LH. Anxiety and persistence of Lyme disease. Am. J. Med. 98 (4A), 74S-78S (1995).